- Takeda is considering a new bid for Adderall drugmaker Shire, raising the share price to 47 British pounds (about $66) per share up from 46.50 per share (about $65), Bloomberg reported Friday.
- Shire has already
- Interest in Shire almost turned into a bidding war between Takeda and Allergan
ADVERTISEMENT
Takeda's considering turning up the heat on its bid for Shire (TKPYY, SHPG)
Shire has already turned down three offers already from the Japanese pharmaceutical company Takeda, including one worth $60 billion.
ADVERTISEMENT
FOLLOW BUSINESS INSIDER AFRICA
ADVERTISEMENT
Recommended articles
Africa's gaming gold rush: Unveiling the surge in online gambling
Seven African countries added to Meta's AI service coverage
10 African countries with the lowest inflation rates in 2024
Davido launches his label Nine+ in partnership with UnitedMasters
Nigeria's economic ranking drops to fourth in Africa
Moscow inaugurates its House of Africa
The CBN justifies $2b billion loss in forex, dispelling Naira defense claims
10 best airports in Africa in 2024